GET THE APP

Biopharmaceutics Group Journals | Open Access Journals

Pharmaceutical Regulatory Affairs: Open Access

ISSN: 2167-7689

Open Access

Submit Manuscript

Biopharmaceutics Group Journals

Biopharmaceuticals are any pharmaceutical medicine thing made in, expelled from, or semi blended from natural sources. Not equivalent to totally arranged pharmaceuticals, they consolidate vaccinations, blood, blood fragments, allergens, physical cells, quality medicines, tissues, recombinant supportive protein, and living drugs used in cell treatment. Biologics can be made out of sugars, proteins, or nucleic acids or complex blends of these substances, or maybe living cells or tissues. They (or their trailblazers or parts) are isolated from living sources—human, animal, plant, infectious, or microbial. Some managerial associations use the terms common helpful things or medicinal normal things to insinuate unequivocally to planned macromolecular things like protein-and nucleic destructive based meds, remembering them from things like blood, blood parts, or vaccinations, which are commonly isolated honestly from a characteristic source.

High Impact List of Articles

Conference Proceedings

Packaging challenge for biosimilar products
Anupam Chanda
Posters & Accepted Abstracts: Journal of Bioanalysis & Biomedicine
Packaging challenge for biosimilar products
Anupam Chanda
Posters & Accepted Abstracts: Journal of Bioanalysis & Biomedicine
Experimental study and modelling of drying kinetics of peppermint tea (Mentha piperita) treated by thermal and biochemical treatment
M Mahrouz, H Machhour, A Idlimam, M Barakate and M Kouhila
Posters-Accepted Abstracts: Journal of Bioprocessing & Biotechniques
Experimental study and modelling of drying kinetics of peppermint tea (Mentha piperita) treated by thermal and biochemical treatment
M Mahrouz, H Machhour, A Idlimam, M Barakate and M Kouhila
Posters-Accepted Abstracts: Journal of Bioprocessing & Biotechniques
The importance of developing and managing a well-defined regulatory strategy
Chitra Edwin
Keynote: Pharmaceutical Regulatory Affairs: Open Access
The importance of developing and managing a well-defined regulatory strategy
Chitra Edwin
Keynote: Pharmaceutical Regulatory Affairs: Open Access
Biosimilar characterization and comparability assessments-Experiences from a CRO GMP protein chemistry laboratory
Leonard Bell
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
Biosimilar characterization and comparability assessments-Experiences from a CRO GMP protein chemistry laboratory
Leonard Bell
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
Reverting antibiotic tolerance of bacterial persisters by a brominated furanone, (Z)-4- bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one
Jiachuan Pan and Dacheng Ren
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
Reverting antibiotic tolerance of bacterial persisters by a brominated furanone, (Z)-4- bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one
Jiachuan Pan and Dacheng Ren
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine

Relevant Topics in Pharmaceutical Sciences

Awards & Nominations

50+ Million Readerbase

Journal Highlights

Google Scholar citation report

Citations: 533

Pharmaceutical Regulatory Affairs: Open Access received 533 citations as per Google Scholar report

Pharmaceutical Regulatory Affairs: Open Access peer review process verified at publons

Indexed In

Related Links

Open Access Journals